Excellence in Dermatology™
Excellence in Dermatologic Surgery™
Excellence in Medical Dermatology™
Excellence in Dermatopathology™

Return to program book search

Session Information

SYM S005 - Comorbidities in Dermatology

Open admission to eligible categories, no tuition or ticket


Date: Friday, March 21

CME Credits: 3.00

Location: Room 102/104/106

Time: 9:00 AM - 12:00 PM

Director: Joel M. Gelfand, MD, MSCE, FAAD

  • Christopher James Miller, MD, FAAD
  • Misha Rosenbach, MD, FAAD
  • David B. Sarwer, PhD - Handout
  • Eric Lawrence Simpson, MD, FAAD - Handout
  • Victoria P. Werth, MD, FAAD - Handout

Learning Objectives:
Following this course, the attendee should be able to:

  • Identify patient factors that increase the risk of bad clinical outcomes
  • Recognize how dermatologic disorders influence the future risk of systemic disease
  • Optimize treatment outcomes through identification and management of comorbid disorders

Nearly one in two Americans (133 million) has one or more chronic health conditions. Comorbidity is defined as the coexistence of two or more medical diseases. Comorbidity is a major public health burden with substantial implications for clinical practice. In this symposium, we will examine the impact of comorbidity on the medical, surgical, and cosmetic dermatology patient. The impact of comorbidity on treatment selection and patient outcome, ways to minimize the risk of treatment-related comorbid conditions, and the impact of chronic skin conditions on the development of new comorbid diseases over time will be emphasized.


  • Crerand CE, Franklin ME, Sarwer DB. Body dysmorphic disorder and cosmetic surgery. Plast Reconstr Surg 2006; 118: 167e-80e.
  • Grossman JM, Gordon R, Ranganath VK et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken); 62: 1515-26.
  • Kimball AB, Gladman D, Gelfand JM et al. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol 2008; 58: 1031-42.


Friday, March 21
9:00 AMOral steroids: Maximizing benefit, minimizing risk / Dr. Werth
9:30 AMComorbidity of pediatric atopic dermatitis / Dr. Simpson
10:00 AMDrug reactions: risk factors and complications / Dr. Rosenbach
10:30 AMDermatological surgery in the medically complex patient / Dr. Miller
11:00 AMPsychiatric disorders in the cosmetic dermatology patient / Dr. Sarwer
11:30 AMPsoriasis comorbidity: getting to the heart of the matter / Dr. Gelfand